From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
ConflictEmerging evidence
What is happening. St. John's Wort may induce CYP3A4 and reduce tolterodine exposure, lowering symptom control.
Mechanism. CYP3A4 induction can lower concentrations of susceptible substrates.
Recommendation. Avoid starting or stopping without monitoring overactive bladder symptoms and adverse effects.
Stack Score
How it moves the number.
Effect on the composite score
If both St. John's Wort and Tolterodine are in the same stack, this pair applies −10 to your Stack Score (per scored conflict row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1U.S. National Library of Medicine. Tolterodine Tartrate Extended-Release Capsules US Prescribing Information. 2026.Needs sourceNo link